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Background: Cervical cancer is the commonest cancer and the leading cause of cancer mortality in women in
Gabon. The age-standardized incidence of cervical cancer is 19.9 per 100 000 women and the mortality rate is 8.4
per 100 000. Various international studies have identified the lack of awareness and knowledge about cervical
cancer as barriers to use preventive methods. This article assesses the awareness and knowledge about cervical
cancer, Pap smear testing and its use and HPV among women living in Libreville, Gabon.
Methods: This study was conducted in October 2014 in Libreville. A total of 452 women aged 16 years and above
were recruited from different town locations. Logistic regression analysis was used to identify the effect of
demographic characteristics on the level of knowledge about cervical cancer, Pap smear testing and HPV. Odds
ratio and 95% confidence intervals were used to identify the strength of association. Associations were considered
statistically significant at p < 0.05.
Results: Of all the women interviewed, 91.6% (414/452) had heard about cervical cancer and only 27.9% (126/452)
had heard of Pap smear test. Of these 126 women, only 65.1% (82/126) had done cervical cancer screening and
68.3% (56/82) on the suggestion of a doctor. The most common reason for not undergoing Pap smear testing was
neglect (50%, 22/44) followed by lack of financial resources (13.6%, 6/44), fear of discovering a serious disease (13.6%,
6/44) and deeming it unimportant (13.6%, 6/44). Only 8% (40/452) of the participants had heard about HPV and their
knowledge of HPV was fair. There is a very poor level of knowledge about cervical cancer among Gabonese women.
Conclusion: This study demonstrates a very low level of knowledge about cervical cancer, Pap smear testing and HPV
in a sample of Gabonese women. There is a critical need for Gabonese women to be informed about cervical cancer
and the Pap smear test to improve the use of this preventive method. The implication of health staff and Gabonese
media should be included as a centerpiece in the effort to inform the population in order to reduce the burden of
cervical cancer in Gabon and save women lives.
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Cervical cancer is the fourth most common cancer
among women worldwide, with an estimated 528,000
new cases and 266,000 deaths in 2012 [1]. Human papil-
lomavirus (HPV) is thought to be the most common
sexually transmitted infection worldwide and more than* Correspondence: m.ennaji@yahoo.fr
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unless otherwise stated.75% of sexually active adults have had HPV infection in
their lifetime [2]. The correlation between the presence of
this virus and the development of precancerous lesions
that may lead to cervical cancer is clearly established.
Cervical cancer is one of the few preventable human
cancers, its prevention is based on the early diagnosis of
precancerous lesions whose treatment generally makes
the development of cancer almost impossible [3]. How-
ever, in developing countries, cervical cancer remains
the most common cause of cancer-related deaths amongtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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mortality of this cancer have decreased significantly be-
cause of the efforts made to detect precancerous lesions
early [5,6].
Despite the high prevalence of cervical cancer, many
studies have shown that women’s knowledge about HPV,
cervical cancer and cervical screening is very low [7-10].
Moreover, the uptake and success of cervical cancer
screening is determined by women’s knowledge and
awareness of cervical cancer [10].
In Gabon, a country in middle Africa, cervical cancer is
considered a major public health problem and is the most
commonly occurring cancer among Gabonese women
[11]. According to the 2012 International Agency for
Research on Cancer (IARC) report, the age-adjusted inci-
dence rate of cervical cancer in Gabon is 19.9 per 100,000
(118 new cases/year) and the mortality rate from cervical
cancer is 8.4 per 100,000 (48 deaths/year)[1].
No data are currently available regarding awareness
and knowledge of cervical cancer, Pap smear screening
and HPV among Gabonese women. Thus, this study
aimed to assess the knowledge and awareness of cervical
cancer, Pap smear testing and HPV in Gabonese women
and reveal which sources of information are commonly
used in their health education.
Methods
Participant recruitment
A questionnaire-based survey, using face-to-face inter-
views, was carried out in October 2014 in Libreville, the
capital of Gabon. Women aged 16 years and above were
approached in different public sites of the town (market,
mall, public garden, church etc.…), thus increasing the
chance of covering women from different social groups.
A total of 452 women agreed to voluntarily participate in
the study. The women were interviewed by two trained re-
searchers who had extensive knowledge of cervical cancer,
screening and HPV. The interviews were conducted in
French, the national language of the country.
Questionnaire data and process
A questionnaire based on a literature review and a previ-
ously published questionnaire [12] was designed in English.
The questionnaire was translated into French and then
translated back into English for quality assurance. The
items on the questionnaire were divided into four sections:
(i) demographic characteristics of the participants, and
awareness, knowledge, and information sources of (ii) cer-
vical cancer, (iii) Pap smear testing and (iv) HPV.
Information on age, marital status, occupation, num-
ber of children, level of education and monthly income
was collected. Monthly income (Central African CFA
Franc) was categorized as “low” (<200 000) “medium”
(200 100–400 000) and “high” (>400 000).During the interview, if the participant had never
heard about cervical cancer, she was asked if she had
ever heard about Pap smear testing. If the answer was
again no, she was asked if she had ever heard about
Human Papillomavirus/HPV. If this answer was also no,
the questionnaire was finished for this participant, to
eliminate answers due to guessing.
Two knowledge scores were created: one for the entire
population of the study and one to measure the knowledge
level about HPV for women who had heard about HPV.
The participants received 1 point for correct answers and 0
for either wrong answers or when the answer was “I don’t
know”. Questions regarding specific knowledge about cer-
vical cancer, Pap smear testing and HPV were considered
to create the overall knowledge score. The knowledge ques-
tions were grouped and the mean score was computed to
determine the overall knowledge of participants. The par-
ticipants who scored average or above were considered as
“knowledgeable” and the others as “not knowledgeable”.
For participants who answered questions about HPV
(on the basis that they had indicated that they had heard
of HPV), three levels of knowledge were defined: a low
level of knowledge (0–2 correct answers), a fair level of
knowledge (3–4 correct answers) and an excellent level
of knowledge (5–6 correct answers).
The questionnaire was piloted on a sample of 10 fe-
male volunteers who were not included in the study.
The interviews lasted 7 minutes on average. At the end
of the questionnaire, an information session about the
disease was given to the participant when they answered
‘yes’ to the last question: “Do you think you need infor-
mation about this disease?”
Ethical considerations
Ethical approval (number: 00287/MS/SG) was obtained
from the “Ministère de la Santé de Libreville”. All partici-
pants gave written consent (for participants 17 years and
below, written consent was obtained in addition to paren-
tal consent). Confidentiality was ensured through the use
of code numbers rather than participants’ names.
Data analysis
Statistical analysis was performed using Epi info6 software
(www.epivf.fr). Logistic regression analysis was used to
identify the effect of demographic characteristics on the
level of knowledge about cervical cancer, Pap smear test-
ing and HPV. Odds ratio and 95% confidence intervals
were used to identify the strength of association. Associa-
tions were considered statistically significant at p < 0.05.
Results
Demographic characteristics of the participants
The mean age of participants was 30.4 years (range 16–65
years). Of the interviewed women, 50.4% (228/452)
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versity level of education (not necessarily completing uni-
versity) and 51.6% (233/452) were employed. The majority
of the women were of low income (69.1%, 312/452).




Never married 228 (50.4)






No school 10 (2.2)
Primary school 12 (2.7)




Medium 72 (15.9)Awareness and knowledge about cervical cancer
Of the 452 participating women, 91.6% (414/452) had
heard of cervical cancer. Among these women, 62.3%
(258/414) felt moderately/extremely concerned about
cervical cancer (Table 2). Only 22.7% (94/414) of women
reported knowing the causes of cervical cancer. The
most frequently cited causes of cervical cancer were abor-
tion and sexually transmitted infection (including HPV)
respectively in 29.8% (28/94) and 28.7% (27/94). The less
frequently cited causes of cervical cancer were early preg-
nancy and high parity (2.1%, 2/94 each).When asked about
the possibility of developing cervical cancer one day,
40.4% (38/94) of women believed they had no risk. Partici-
pating women acquired information about cervical cancer
mostly from either foreign media or medical workers:
28.5% (118/414) and 27.1% (112/414) respectively. Results
regarding cervical cancer, Pap smear testing and HPV in-
formation sources are presented in Table 2.High 68 (15.0)
N = Number of respondents.
Percentage are shown in parentheses.Awareness, knowledge and attitude toward Pap
smear testing
Only 27.9% (126/452) of the study participants had heard
about cervical cancer prevention through screening.
Among these, 65.1% (82/126) had had a Pap smear previ-
ously. The principal motivation to undergo Pap smear
testing as cited by these women was “the demand of their
doctor” (68.3%, 56/82). Some women reported being
embarrassed about the test (61%, 50/82) and had experi-
enced pain during screening (34.1%, 28/82). The main rea-
son given by women who had never been screened for
cervical cancer but had heard about it was neglect (50%,
22/44). Table 3 summarizes the knowledge and attitudes
about cervical screening in the study population.Awareness and knowledge of HPV
Among all the participants, only 8.8% (40/452) had
heard of HPV. The majority of respondents reported
that HPV is the principal risk factor of cervical cancer
(65%, 26/40) and was acquired sexually (70%, 28/40)
(Table 4). The answers to the HPV questions were used
to create a knowledge score. Analysis revealed that 35%
(14/40) of women had a low level of knowledge (0–2
correct answers), 60% (24/40) had a fair level of know-
ledge (3–4 correct answers), and only 5% (2/40) had a
high level of knowledge (5–6 correct answers).Factor related to level of knowledge
Knowledge of cervical cancer, Pap smear testing and
HPV was related to the socio-demographic characteris-
tics of the participants. The women generally demon-
strated a poor level of knowledge (93.6%, 423/452). Older
participants, those who had ever been married and those
with medium to high monthly incomes were more likely
to have a good knowledge (Table 5).
Discussion
The current study is the first to explore the level of
knowledge and awareness of cervical cancer, Pap smear
testing and HPV in Gabonese women. The findings reflect
a poor level of knowledge. Such findings have been re-
ported by a number of previous studies in other African
communities [7,8,13-15] and was not a surprising cause in
this part of the world effort to inform population about cer-
vical cancer is still lacking. Different socio-demographic
variables such as higher income, older age and being mar-
ried were found to be predictors of a good knowledge level
of cervical cancer. The findings from the current study are
consistent with several other African studies [7,8,16]. How-
ever, in the current study, the level of knowledge was not
associated with the participants’ occupation or educational
Table 2 Participants’ awareness and knowledge of
cervical cancer, and information source about cervical
cancer, Pap smear testing and HPV
Questions N
Have you ever heard of cervical cancer?
No 38.0 (8.4)
Yes 414.0 (91.6)
Are you concerned about having/developing
cervical cancer?1
No 90.0 (21.7)
A little 66.0 (15.9)
Moderately 96.0 (23.2)
Extremely 162.0 (39.1)




Risk factors for cervical cancer cited by
the respondents*
Abortion 28.0 (29.8)
Sexually transmitted infection 27.0 (28.7)
Smoke 21.0 (22.3)
Multiple partners 19.0 (20.2)
Insert products/fingers into the vagina 17.0 (18.1)
Sex at an early age 14.0 (14.9)
Lack of hygiene 10.0 (10.6)
Alcohol/Drug 7.0 (7.5)
Excessive sex 4.0 (4.3)
Heredity 3.0 (3.2)
High parity 2.0 (2.1)
Early pregnancy 2.0 (2.1)
Self-perceived chance of developing cervical cancer2?
Non existent 38.0 (40.4)




Information source about cervical cancer?
Foreign media 118.0 (28.5)
Gabonese media 112.0 (27.1)
Medical staff 108.0 (26.0)
Family/friends 76.0 (18.4)
Information source about Pap smear test?
Medical staff 66.0 (52.4)
Foreign media 30.0 (23.8)
Gabonese media 16.0 (12.7)
Family/friends 14.0 (11.1)
Table 2 Participants’ awareness and knowledge of
cervical cancer, and information source about cervical
cancer, Pap smear testing and HPV (Continued)
Information source about HPV?
Foreign media 26.0 (65.0)
Medical staff 14.0 (35.0)
Gabonese media 0.0 (0.0)
Family/friends 0.0 (0.0)
N = Number of respondents.
1Only for women who have heard about cervical cancer.
2Only for women who cited at least one risk factors of cervical cancer.
*This was an open question; the total percentage can exceed 100% because
of multiple answers.
Percentage are shown in parentheses.
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(including postgraduate students) in the interviewed
women and the type of courses studied by these women. In
Gabon there is no information program about cervical can-
cer available to students other than those enrolled in the
health academic program. These findings highlight the need
to inform students about cervical cancer by introducing in-
formative programs into the education system.
In this study, 91.6% (414/452) of women had heard
about cervical cancer but only 22.7% (94/414) reported
knowing the causes of cervical cancer. However, there
were common knowledge gaps concerning the risk fac-
tors of cervical cancer. The risk factors that were most
frequently cited included abortion, sexually transmitted
infection, smoking, multiple sexual partners, inserting
products/fingers into the vagina, sex at an early age and
lack of hygiene. In African societies, incorrect risk fac-
tors for cervical cancer such as abortion, lack of hygiene
and the insertion of products/fingers into the vagina are
commonly cited by women [8,13]. This suggests that ac-
curate information about cervical cancer and its causes
needs to be available to women through mass campaigns
that also dispel false traditional beliefs about cervical
cancer. The others risk factors commonly cited by
women were related to sexual comportment and were
identified in the literature as risk factors for cervical can-
cer [17]. Smoking was cited as a risk factor for cervical
cancer by 22.3% (21/94) of participants in the current
study. In many African studies, the risk posed by smok-
ing is unknown or cited by a small proportion of women
[8,13,16,18]. Findings from the current study suggest
that Gabonese women predominantly associate cervical
cancer with sexual behavior. High parity, early age at
first pregnancy, heredity, excessive sex and alcohol/drug
were less frequently cited by the women. High parity and
early age at first pregnancy have been described in the lit-
erature as risk factors for cervical cancer [17,19]; however,
the role of heredity and alcohol/drug use remains unclear
[17,20]. A high proportion of women (62.3%) reported that
Table 3 Knowledge and attitudes toward the Pap
smear test
Questions N
Have you ever heard about Pap smear test?
No 326 (72.1)
Yes 126 (27.9)
We use pap smear test*:
To prevent cervical cancer 108 (85.7)
To prevent infection in genital tract of women 34 (27.0)
To prevent sexual transmitted infection in general 6 (4.8)




At one time 40 (48.8)
2-3 times 34 (41.5)
>3times 8 (9.8)
Motivation to undergone a pap smear test:
On demand of doctor 56 (68.3)
By yourself 12 (14.6)
Both 14 (17.1)






Normal frequency for doing pap smear test:
Every year 64 (78.1)
Every 2-3years 18 (21.9)
Reasons for not making pap smear test:
negligence 22 (50.0)
I don’t have the financial resources 6 (13.6)
I think it is not important 6 (13.6)
I am afraid to discover a grave disease 6 (13.6)
I am afraid of pain 4 (9.1)
N = Number of respondents.
Percentage are shown in parentheses.
*Can exceed 100% because of multiple answers.
Table 4 Participants’ knowledge of HPV*
Questions Participant’s correct answer
HPV can cause urinary infection? 8(20%) false
HPV is the principal risk factor of
cervical cancer?
26 (65%) yes
HPV can cause genital warts? 20 (50%) yes
HPV infect only women? 16 (40%) false
HPV is a sexually transmitted infection? 28 (70%) yes
Condom gives total protection
against HPV?
20 (50% )false
*Only for the 40 women who have heard about HPV.
Table 5 Socio-demographic characteristics that correlate
to the level of knowledge about cervical cancer among
Gabonese women
Knowledge of cervical cancer, pap smear test and HPV (N = 452)
Variables Yes, N = 29
(6.4%)




<30 7 (2.6%) 261 (97.4%) 7.5 (2.0-27.6)*
30-39 8 (7.7%) 96 (92.3%) 2.4 (0.7-8.7)
40-49 10 (17.9%) 46 (82.1%) 0.9 (0.3-3.3)
≥50 4 (6.7%) 20 (83.3%) 1
Occupation
Student 4 (2.2%) 180 (97.8%) 2.7 (0.5-15.5)
Not employed 2 (5.7%) 33 (94.3%) 1
Employed 23 (9.9%) 210 (90.1%) 0.5 (0.1-2.5)
Educational level
No school 0 (0.0) 10 (100%) 1
Primary education 0 (0.0) 12 (100%) 1.2 (0.02-65.3)
Secondary education 0 (0.0) 142 (100%) 13.6 (0.2-718.9)
University 29 (10.1%) 259 (89.9%) 0.4 (0.02-7.3)
Marital status
Never married 9 (3.9%) 219 (96.1%) 1
Ever married 20 (8.9%) 204 (91.1%) 0.4 (0.2-0.9)*
Montly household income
Low 6 (1.9%) 306 (98.1%) 1
Medium 6 (8.3%) 66 (91.7%) 0.2 (0.1-0.7)*
High 17 (25%) 51 (75%) 0.1 (0.02-0.2)*
Parity
Nulliparous 6 (3.7%) 155 (96.3%) 1
At least one child 23 (7.9%) 268 (92.1%) 0.5(0.2-1.1)
*Statistically significant.
Average knowledge score = 8.5.
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developing cervical cancer. However, 40.4% of women
believed that they were at no risk of developing cervical
cancer. In this scenario, it is important to correct
the false perceptions about cervical cancer among
Gabonese women.
In Gabon, although cervical cancer has been selected as
a priority disease, a national organized cervical cancer
screening program is still lacking. Individual opportunisticscreening is practiced and some organizations politically
affiliated offer rare screening campaigns. The current
study reveals that a little part of the respondents (126/452;
27.9%) had heard about Pap smear screening and 65.1%
(82/126) of these women had already had a Pap smear test.
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tested was the recommendation of their doctor, which
classifies their screening as an opportunistic. In a study
among Hispanic women, Austin et al. [21] reported that
the recommendation of a doctor is a strong motivation to
be screened for cervical cancer. This finding has also been
reported among Chinese-Australian women by Kwok
et al.[22]. In Africa, Obi et al. [23] reported the same result
among Nigerian women. These findings highlight the im-
portance of medical workers in informing women about
cervical cancer and screening. However, the majority of
screened women (61.0%, 50/82) reported being embar-
rassed during Pap smear testing. This feeling has been
identified as an obstacle for having repeat Pap smear tests
in studies conducted among Brazilian [12], Hispanic [24]
and Qatari [25] women and should be taken into account
to increase the compliance of women in the practice for
cervical cancer screening.
In the present study, the major barrier cited by women
in use for cervical cancer screening was negligence; fear
of discovering a serious disease was also cited by the
interviewed women. These barriers to screening were
mentioned in previous studies [7,26]. Negligence may
suggest the need for an aggressive information campaign
about this disease. However, fear reflects a poor under-
standing of the natural history of cervical cancer and of
the principle behind cervical cancer screening. More-
over, this suggests that the acceptability of cervical
screening could be high if women were simply informed.
Several studies have reported that knowledge of HPV
was low in developing countries [27-30] compared with
some developed countries [31,32]. This discrepancy is
due to the effort to inform the population about HPV
and vaccination. The results of the current study are
concordant with the existing literature on HPV know-
ledge. Indeed, only 8.8% (40/452) of the participants had
heard about HPV. In contrast, a study conducted in
Australia, where a school-based National HPV Vaccin-
ation and information Program about HPV is available,
found that the majority (88.9%) of women had heard of
HPV [33]. In Gabon, despite the availability of the HPV
vaccines, they are not promoted by the authorities.
These findings emphasize the need to improve under-
standing of the link between HPV and cervical cancer in
Gabonese women.
Some limitations of the present study should be men-
tioned. The high proportion of women educated to uni-
versity level (postgraduate student) is not representative
of the general Gabonese population. The inclusion
method is likely the main reason for this bias because
the study population mainly included women who were
not at work during the recruitment times and were
present in the public sites. A sample size was not calcu-
lated because of the descriptive nature of this study andthe unavailability of previous information about the
topic. However, this is the first exploratory study of
women’s knowledge about cervical cancer, Pap smear
testing and HPV in Gabon and it reveals the need to in-
form Gabonese women about cervical cancer in Gabon.
Conclusion
Our study highlights the lack of knowledge about cervical
cancer in Gabonese women. There is a real necessity to in-
form Gabonese women about cervical cancer screening.
Education campaigns involving the local media may be a
good approach to inform Gabonese women.
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